Publication

Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer.

van As, Nicholas
; 
Griffin, Clare
; 
Tree, Alison
; 
Patel, Jaymini
; 
Ostler, Peter
; 
van der Voet, Hans
; 
Loblaw, Andrew
; 
Chu, William
; 
Ford, Daniel
; 
Tolan, Shaun
... show 10 more
Abstract
Whether stereotactic body radiotherapy (SBRT) is noninferior to conventionally or moderately hypofractionated regimens with respect to biochemical or clinical failure in patients with localized prostate cancer is unclear.
MIDER Authors
Ford, Daniel
Citations
Altmetric:
Date
2024
Type
Article
Other
Subject
Collections
UHCW Oncology
UHB Oncology
Show all metadata
Citation
N. van As, C. Griffin, A. Tree, J. Patel, P. Ostler, H. van der Voet, A. Loblaw, W. Chu, D. Ford, S. Tolan, S. Jain, P. Camilleri, K. Kancherla, J. Frew, A. Chan, O. Naismith, J. Armstrong, J. Staffurth, A. Martin, I. Dayes, P. Wells, D. Price, E. Williamson, J. Pugh, G. Manning, S. Brown, S. Burnett, and E. Hall
Journal / Source Title
The New England Journal of Medicine
DOI
10.1056/NEJMoa2403365
URI
http://hdl.handle.net/20.500.14200/6469
PMID
39413377
Publisher
Massachusetts Medical Society
Publisher’s URL
DOI: 10.1056/NEJMoa2403365
Publisher’s statement
Note / Copyright